🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to confirm that combination of Narlaprevir, Ri...
Status
Completed
Location
FBIS CSRI of Epidemiology of Federal Service on Customers
Start Date
2017-11-27
Trial ID
NCT03485846
Treatments Being Tested
SCH 900518 is a potent oral inhibitor of HCV NS3 protease which disrupts he...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00797745
Treatments Being Tested
Multicenter, open-label, phase II safety and efficacy study of all-oral com...
Status
Completed
Location
FBIS CSRI of Epidemiology of Federal Service on Customers
Start Date
2019-05-06
Trial ID
NCT04246723
Treatments Being Tested
This study was conducted to evaluate narlaprevir (NVR) pharmacokinetics (PK...
Status
Completed
Location
LLC Chapidze Emergency Cardiology Center
Start Date
2013-11-08
Trial ID
NCT03832426
Treatments Being Tested
Study P05063 is a 3-year long-term follow-up (LTFU) study in participants p...
Status
Terminated
Location
Multiple Locations
Start Date
2007-02-20
Trial ID
NCT00689390
Treatments Being Tested
The study purpose is to evaluate the potential for a pharmacokinetic drug-d...
Status
Completed
Location
Clinic "Bessalar" JSC
Start Date
2017-04-24
Trial ID
NCT03537404
Treatments Being Tested
Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynami...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT01081158
Treatments Being Tested
The purpose of this study was to confirm that combination of narlaprevir (N...
Status
Completed
Location
South-Ural State Medical University, Clinic of Medical Academy, Infectious Diseases Department
Start Date
2014-05-07
Trial ID
NCT03833362